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ABSTRACT 
Background: The DECODE method integrates differential co-expression and differential 
expression analysis methods to better understand biological functions of genes and their 
associations with disease. The DECODE method originally was designed to analyze large 
sample gene expression experiments, however most gene expression experiments consist of 
small sample sizes. This paper proposes modified test statistic to replace the traditional test 
statistic in the DECODE method. Using three simulations studies, we compare the performances 
of the modified and traditional DECODE methods using measures of sensitivity, positive 
predictive value (PPV), false discovery rate (FDR), and overall error rate for genes found to be 
highly differentially expressed and highly differentially co-expressed. 
Results: In comparison of sensitivity and PPV a minor increase is seen when using 
modified DECODE method along with minor decrease in FDR and overall error rate. Thus, a 
recommendation is made to use the modified DECODE method with small sample sizes.  
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CHAPTER 1. INTRODUCTION 
Differential expression analysis has been extensively studied in the gene expression 
experiments. However the past decade has led to advances and a gain in popularity of differential 
co-expression analysis. Though there have been advances in the individual fields of differential 
expression and differential co-expression, there have been few methods that consider these two 
methods of analysis together. The DECODE method, Differential Co-Expression and 
Differential Expression, was created by Thomas WH Lui et. al. to merge these two forms of gene 
expression analysis. The DECODE method is built to handle two condition studies, where one 
would be considered ‘normal’ state and the second would be the condition of interest referred to 
as the ‘disease’ state.  
The original DECODE method was created to analyze large sample gene expression 
studies. However, an overview of the National Center for Biotechnology Information (NCBI) 
site shows that most gene expression studies have small samples (Gene Expression Omnibus, 
2018). For this reason, we propose using the moderated test statistic to better estimate the 
variances in small sample gene expression studies (Smyth, 2004).  
This paper will compare the performance of the DECODE method using the traditional 
test statistic and the moderated test statistic with the goal of determining if the moderated test 
statistic is advantageous for smaller samples. In order to determine if it the moderated test 
statistic improves the performance of the DECODE method; we will compare the sensitivity, 
positive predictive value, false discovery rate, and the overall error for the DECODE method 
when the traditional and moderated test statistics are used. The microarray data used for the 
analysis was obtained from the NCBI website. 
 2 
This thesis is organized as follows. Chapter 2 provides an introduction to differential 
expression analysis and differential co-expression analysis. Chapter 3 provides the methodology 
of the DECODE method using the traditional test statistic and the moderated test statistic as well 
as a description of the simulation studies. Results from these simulations will be reported in 
Chapter 4 followed by the Conclusion and Discussion in Chapter 5. 
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CHAPTER 2. LITERATURE REVIEW 
2.1. Differential Expression 
Gene expression is the quantification of the ‘abundance’ of mRNA corresponding to a 
gene in an organism. An individual gene’s expression may change from cell to cell depending on 
the needs of the cell. For example if a cell is affected by a condition or disease, that cell may be 
in need of more or less mRNA from a particular gene.  
In differential expression analysis, we seek to find a set of genes that are differentially 
expressed (DE) between two or more conditions. In many approaches, this involves performing a 
hypothesis test for each gene. For each test, the null hypothesis is that the gene is equivalently 
expressed (EE) i.e., that there is no difference in the average mRNA abundance between the 
conditions and the alternative hypothesis is that the gene is differentially expressed, i.e. that there 
is a difference in the average mRNA abundance levels between the conditions. If we fail to reject 
the null hypothesis, there is not enough evidence to conclude the gene is DE. If we reject the null 
hypothesis, there is enough evidence and the gene is declared to be differentially expressed 
(DDE). As with any hypothesis test, we are unable to say with complete confidence that that 
specific gene is truly DE even if it is DDE. 
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Many different methods have been proposed including parametric and nonparametric 
approaches. Traditional statistical methods can be applied to each gene in a gene expression 
experiment, such as the traditional t-test and F- test, to test for differential expression. However, 
with tens of thousands of genes being tested in a typical experiment, there needs to be a 
correction on the resulting p-values in order to control multiple testing error. Methods used to 
control family-wise error rate include Bonferroni, Holm’s, and Scheffe (Bonferroni, 1936), 
(Holm, 1979), (Lindley, 1999). Methods used to control false discovery rate, the preferred 
multiple testing error to control in most gene expression studies include Benjamini and 
Hochberg, and q-values (Benjamini, 1995) (Storey, 2003). A common parametric method for 
differential expression is the moderated t test and is considered an improvement over the 
traditional t test (Smyth, 2004).  
The moderated t test was created by Gordon K. Smyth et. al. with the goal of improved 
estimation of gene-wise variances. When sample sizes are small, the sample variance tends to be 
an unstable estimate of the population variance, resulting in an unreliable traditional t test 
statistic. An assumption of the moderated t test approach is that the variances in gene expression 
differ from gene to gene, but follow an inverse gamma distribution. In order to estimate the 
parameters of this distribution, this approach uses empirical Bayesian methods to borrow 
information from all genes to better estimate the variance of an individual gene. More 
information on this method is provided in Chapter 3. 
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The parametric tests described above assume normality assumptions hold. When these 
assumptions are not met, nonparametric approaches can be applied as they do not assume 
normality. Some of the more common nonparametric methods are the Significance Analysis of 
Microarrays Method (SAM) (Tusher, 2001) and the Wilcoxon sum rank test (Troyanskaya, 
2002). The SAM method is a permutation procedure in which the test statistic, similar to a 
traditional t-test statistic, is compared to the distribution of test statistics from permuted data sets. 
The Wilcoxon sum rank test determines if the sum of ranks of expressions from one condition is 
significantly higher or lower than what would be expected if the expression values from each 
condition come from the same distribution. 
2.2. Differential Co-Expression 
While differential expression has been around for the past two decades, the idea of 
looking of differential correlation is a newer topic in the field of gene expression. Differential 
correlation can also be referred to as differential co-expression while both denoted DC, which 
term to use is often left up to the author. We are going to consider two main ideas behind 
differential co-expression. The first was stated by de la Fuente A. that correlation between a set 
of given genes could affected by a given disease or treatment (de la Fuente, 2010). The second is 
that it is conceivable that genes are correlated due to a causational relationship. 
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In “Loss of Connectivity in Cancer Co-Expression Networks” Anglani et. al. found 
evidence to support the claim that abundance levels are not always effected in a way that can be 
seen by differential expression. This study found that there was a significant decrease in 
correlation (Roberto A., 2014). This is considered evidence to support the first idea of 
differential co-expression, correlation can change for a given condition while not affecting 
abundance levels. More studies have also found evidence for this claim (Amar, 2013) (Watson, 
2006). 
The second main idea contemplates that two or more genes are correlated due to a 
causational relationship, also referred to as functional relationships. By locating these functional 
relationships, we are able to find another starting point in gene analysis. For example, Cho S. et. 
al. uses this idea in Identifying Set-Wise Differential Co-Expression in Gene Expression 
Microarray Data to create differentially coexpressed genes sets algorithm (dCoxS) to find gene 
set pairs that have a causational relationship (Cho, 2009).  
According to Wang et. al there are three different ways that DC can be represented. The 
first is referred to as the “shift”. When the shift takes places, the correlations of the genes are not 
affected however the expression levels are affected (i.e., they are DE). The second way DC can 
be represented is referred to as the cross. When a cross takes place genes may be positively 
correlated under one condition but negatively correlated under another condition. Finally there is 
the “re-wiring” where genes are either positively or negatively correlated under one condition 
but not correlated or less correlated under another condition (Wang, 2017). 
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One method that can be used to determine differential correlation is Bayes Factor to 
Differential Co-expression Analysis (BFDCA). The BFDCA method consists of five phase, one 
phase uses Bayes factors to determine highly correlated genes after discarding low Bayes factors 
values, the larger values are used to connected possible collaborating genes (Wang, 2017). 
Another method is used in ‘Find disease specific alterations in co-expression of genes’ where 
they created a score for differential co-expression. Using an additive model for each gene pair to 
get the corresponding differential co-expression score, they find a set of genes that are DC. A 
gene pair is declared to be DC when resulting in a low differential co-expression score (Kostka, 
2004) 
Another differential co-expression method that will be used in this thesis is the Z 
measure. From ‘differential expression’ to differential networking’- Identification of 
Dysfunctional Regulatory Networks in Disease by de la Fuente A. et. al. considers the option to 
test if the correlation between two genes differs between two conditions. More detail on this 
formula will be found in 3.1.1. In order to use this method, there must be more than three 
replicates per treatment group. This test statistic is considered more reliable when there are more 
than 10 replicates (de la Fuente, 2010). However all of these methods fail to consider differential 
expression along with differential co-expression.  
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CHAPTER 3. METHODOLGY 
3.1. DECODE Method 
The DECODE method, created by Lui et. al. combines two popular methods for 
analyzing gene expression data- differential expression analysis and differential co-expression 
analysis.  The motivation behind this approach was to find a way to integrate these two methods 
to better understand how genes work together differently in different conditions. In order to 
integrate these two methods, each gene is classified as high or low differentially expressed and 
high or low differential co-expressed to create four different types of genes, referred to as 
partitions. The four partitions are low DE low DC (LE/LC), low DE high DC (LE/HC), high DE 
low DC (HE/LC), and high DE high DC (HE/HC). The DECODE method can be broken down 
into three steps: calculation of test statistics, partition creation, and evaluation of functional 
relevance. This thesis will focus on the first two steps. 
It should be noted that there are two main technologies used to retrieve mRNA 
abundance levels: microarray technology and RNA Next Generation (RNA-seq) technology. The 
DECODE method requires the use of microarray data. Microarray data is considered to be 
continuous versus RNA-seq data which produces count data. This thesis focuses on the analysis 
of microarray data. 
3.1.1. Phase One: Test Statistics 
The DECODE method begins by finding measures for differential expression and 
differential co-expression. A measure of differential expression is found for each gene by 
calculating the absolute value of a traditional t test statistic. That is, for a given gene 𝑖,  
|𝑡𝑖| =
|𝑥𝐷̅̅ ̅ − 𝑥𝑁̅̅̅̅ |
√
𝑠𝐷2
𝑛𝐷
+
𝑠𝑁2
𝑛𝑁
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where ?̅? represents the average gene expression level, 𝑠2 represents the sample gene expression 
variance, the test statistics denoted N represent the normal sample and D represents the disease 
samples values, and lastly  𝑖 = 1…𝑚 and 𝑚 is the number of genes. Not that the direction of 
regulation (up or down) does not impact this measure. In order to find differential co-expression, 
the Z measure is used (de la Fuente, 2010). The first step in finding the Z measure is by 
calculating the Pearson correlation coefficient for each pair of genes in each condition. Let rij
N 
and rij
D represents the normal (N) and the disease (D) state correlation coefficients respectively, 
between the i
th
 and j
th
 genes.  Then the Fisher-transformation on these coefficients is performed, 
so that zij
N and zij
D are both assumed to be approximately normally distributed: 
zij
N =
1
2
ln |
1 +  rij
N
1 −  rijN
| 
zij
D =
1
2
ln |
1 +  rij
D
1 −  rijD
| 
We are now able to calculate the Z measure for genes 𝑖 and 𝑗 from 𝑖 = 1…𝑚 and 𝑗 = 1…𝑚: 
Zij =  
|zij
N − zij
D|
√
1
nN − 3
+
1
nD − 3
 
It is important to note that to implement this method; the smallest possible sample size for each 
state is four.  
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3.1.2. Phase Two: Partition Creation 
For each gene, the differential expression and differential co-expression test statistics are 
used to select thresholds for classifying genes as high or low DE and high or low DC. The 
thresholds are selected by maximizing the test statistic for Pearson’s Chi-Squared Test of 
Association for each gene 𝑗. Consider gene 𝑗. For each pair of threshold candidates, 𝑡𝑖 and 𝑍𝑖𝑗 , 
the genes are divided into the four partitions given the selected thresholds, the total. The total 
threshold candidates will be 𝑚, the number of genes. The four thresholds are defined as follows:  
Low DE and Low DC (LE/LC) = { (tk, zkj),  where zkj < zij and tk < ti} 
High DE and Low DC (HE/LC) = { (tk, zkj),  where zkj < zij and tk ≥ ti} 
Low DE and High DC (LE/HC) = { (tk, zkj),  where zkj ≥ zij and tk < ti} 
High DE and High DC (HE/HC) = { (tk, zkj),  where zkj ≥ zij and tk ≥ ti}  
After partitioning all of the genes we are able to construct a two by two contingency table 
(Table 3.1.), which will be used to find the Pearson’s Chi-Squared Test statistic: 
𝜒2 =∑∑
(𝑚𝑖𝑗 − 𝜇𝑖𝑗)
2
𝜇𝑖𝑗
2
𝑗=1
2
𝑖=1
 𝑎𝑛𝑑 𝜇𝑖𝑗 =
𝑚𝑖+𝑚+𝑗
𝑚
 𝑓𝑜𝑟 𝑖 = 𝑗 = 1,2 
where 𝑚𝑖𝑗 represents the observed genes in the partition, 𝑚𝑖𝑗 represents the partition mean, 𝑚𝑖+ 
represents the sum of the 𝑖th row, and 𝑚+𝑗 represents the sum of the 𝑗
th
 column. There will be a  
total of 𝑚 test statistics, for each gene 𝑗. There is a total of 𝑚 chi-squared test statistics due to the 
𝑚 values of 𝑍𝑖𝑗 for each gene 𝑗. Once all of the test statistics have been found, the thresholds that 
produces the largest chi-squared value is chosen as the optimal thresholds for that given gene 𝑗. 
This process is then repeated for each gene. The DECODE method then finds a functional gene 
set that corresponds to the genes found in the high DE and high DC partition. However, this 
paper will focus only on assess the gene partitions (Lui, 2015). 
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Table 3.1. 
Gene Partition Contingency Table  
  Low DC High DC   
Low DE 
Observed 
LE/LC genes  
Observed  
LE/HC genes m1+ 
High DE 
Observed 
HE/LC genes  
Observed  
HE/HC genes m2+ 
  m+1 m+2 m 
 
3.1.3. Working Example 
Consider a gene expression experiment with 10 genes. We begin implementing the 
DECODE method with phase one by finding the differential expression test statistics and the 
differential co-expression test statistics. There will be 10 measures of differential expression and 
100 measures of differential co-expression with (10 co-expression measures for each of our 10 
genes). 
After finding the measures of differential expression and differential co-expression we 
can begin phase two. Consider gene 1. For this gene, we have one measure of DE and 10 of DC. 
There will be 10 possible thresholds for the first gene (Table 3.2.).  
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Table 3.2. 
Working Example DE and DC Test Statistics (Threshold Possibilities) 
Gene ti  Zi1 
1 2.3330 0.0000 
2 8.9016 2.2206 
3 0.4418 2.3145 
4 3.7379 1.1651 
5 0.7005 0.4063 
6 5.7478 0.5091 
7 10.6974 2.1106 
8 0.9524 1.5619 
9 12.2317 0.5635 
10 3.2451 0.6268 
 
 For each threshold pair we will classify a gene as LE/LC, LE/HC, HE/LC, HE/HC. For 
example, using the gene 2 as the threshold will produce the follow results. 
 
Figure 3.1. Working Example Partitions for Gene 1 using Gene 2 Thresholds Graphic Example 
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Table 3.3. 
Partition Contingency Table for Gene 1 using Gene 2 Thresholds  
2nd Gene Low DC High DC  
Low DE 6 μ11 = 5.6 1 μ12 = 1.4 m1+ = 7 
High DE 2 μ21 = 2.4 1 μ22 = 0.6 m2+ = 3 
 m+1 = 8 m+2 = 2 m = 10 
 
For the thresholds (8.9016, 2.2206), Gene 1 (tk, zik) = (2.333,0)  would be classified as 
LE/LC, as 0 is less than the DC threshold of 2.2206 and 2.33 is less than the DE threshold of 
8.9016. After partition all of the genes using Gene 2 as the cutoff we are able to find the 
Pearson’s Chi-Squared Test Statistic of 0.48. This process is then repeated using each gene test 
statistics as the thresholds. After all 10 Pearson’s Chi-Squared Test Statistics are obtained the 
largest is chosen as the optimal threshold for Gene 1. This process is repeated for Gene 2 to Gene 
10, resulting in 10 optimal thresholds. 
3.2. Moderated Approach 
The DECODE method was created to analyze gene expression experiments with large 
sample sizes, where the traditional t-test statistics are reliable due to the reliable estimation of the 
gene-wise variance. However, most gene expression experiments have small sample sizes due to 
the cost of running experiments. Due to the small sample size the variance components for each 
gene are not well estimated. To mitigate this problem, Smyth et al. created the moderated t test to 
better estimate the gene-wise variances by taking into account the data from all genes in an 
experiment.  
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The moderated t test uses empirical Bayesian methods to estimate prior and posterior 
distributions of the gene-wise variances. Assuming independence across all genes, the posterior 
distribution of the variances has the following inverse gamma distribution:  
(
1
σi2
| 𝑠𝑖
2, 𝑑𝑜 , 𝑠𝑜
2) ~ Gamma(
d +  do
2
,
dsi
2 + doso
2
2
) 
where d is the  degrees of freedom for the traditional t-test, 𝑠𝑖
2 stands for the variance of the i
th
  
genes, 𝑑𝑜 stands for the  prior degrees of freedom, and 𝑠𝑜
2 stands for the prior variance. The 
prior terms 𝑑𝑜 and 𝑠𝑜
2  are estimated from the data. Now our new estimate of the variance for the 
i
th
 genes is: 
s̃i
2 =
dsi
2 + doso
2
d +  do
 
and our new test statistic for differential expression is as follows, using the absolute value 
|t̃i| =
|𝑥𝐷̅̅ ̅ − 𝑥𝑁̅̅̅̅ |
√s̃i
2 ∗ (
1
nD
+
1
nN
)
 
After finding the moderated test statistic the rest of the DECODE method will be performed in 
the same manner. 
3.3. Simulations  
We performed three different simulation studies in order to compare the traditional and 
moderated DECODE methods. We first simulated gene expression data using the normal 
distribution, followed by real gene expression microarray data from two different experiments. 
The first set of microarray simulations was performed on human breast cancer data paired with 
normal tissue, and the second set of microarray simulations was performed on psoriatic patients 
with normal control patients. 
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For each simulation set up, the partition on the gene that returned the largest chi-squared 
value from the regular test statistic method was chosen for analysis. Then the same gene was 
chosen from the moderated test statistic results. The highest chi-squared value is also associated 
with the lowest p-value, and was chosen with the idea that that partition was the most accurate.   
We will use sensitivity, positive predictive value (PPV), false discovery rate (FDR), and 
the overall error rate in interpreting whether the moderated test statistic improves the DECODE 
method when samples sizes are small. In order to obtain the values needed for the interpretation 
we need to think about the results as a two by two contingency table for the sample and 
population values. The population values are obtained by replacing the sample values in the test 
statistic formulas for the population values. The population test statistic for the traditional t test is 
as follows: 
|𝑡𝑖| =
|𝜇𝐷 − 𝜇𝑁|
√
𝜎𝐷2
𝑛𝐷
+
𝜎𝑁2
𝑛𝑁
 
and the population test statistic for the moderated t test is  
|t̃i| =
|𝜇𝐷 − 𝜇𝑁|
√σ̃i
2 ∗ (
1
nD
+
1
nN
)
 
The method used to find the population values for each simulation can be found in the simulation 
methodology. 
An example of how the table is constructed can be found in Table 3.4. The table value A  
represents the genes identified as high DE high DC by the DECODE method that are truly 
HE/HC based on the population test statistics, B represents the genes found to be high DE high 
DC by the DECODE method that are not truly HE/HC based on the population test statistics, C 
represents the genes found to be high DE high DC by the DECODE method that are truly 
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HE/HC, and finally D represents the genes not found to be high DE high DC that are not truly 
HE/HC. 
Table 3.4. 
Correct HE/HC Values for Population and Sample Results (Notation Example) 
  Population  
Sample   HE/HC Not 
  
HE/HC A B 
Not C D 
 
The following formulas were then used to find sensitivity, PPV, FDR, and the overall 
error rate.  
Sensitivity =
A
A + C
 
PPV =
A
A + B
 
FDR = 1 − PPV 
Overall Error Rate =
B + C
m
,where m is the number of genes 
The sensitivity is the proportion of genes that are truly HE/HC found to be HE/HC by DECODE.  
If the moderated test statistic performs better than the regular this value will be higher for the 
moderated results. The PPV is the proportion of the genes that are truly HE/HC among the genes 
identified as HE/HC. If our moderated test statistic performs better this value should also be high 
for the moderated results. FDR is thought of as the false positive rate, or the proportion of genes 
identified as HE/HC that are truly not HE/HC. The goal is to have a smaller FDR, so in return we 
want the moderated results to have a smaller FDR, if it truly performs better.   
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The simulations were set up in order to examine whether our sensitivity, PPV, FDR, and 
the overall error rates will change as the number of genes increase and also how they are affected 
by the sample size of the experiment. For each of the microarray simulations the sample size and 
number of genes are fixed, since they were chosen ahead of time. 
3.3.1. Normal Simulations 
Our normal simulations were done by simulating gene expression data into four 
partitions. For example, for simulations using 40 genes we simulated 10 we considered to be 
high DE high DC, 10 we considered to be high DE low DC, 10 we considered to be low DE high 
DC, and lastly 10 we considered to be low DE low DC. However, it is important to note that 
these partitions do not directly correspond to the four partitions earlier described. The earlier 
partitions are determined for each gene based on the population values. 
Our gene expression data was simulated from a multivariate normal distribution with the 
following mean and correlations found in Table 3.5. In order to simulate the difference between 
low and high DC, the highly correlated genes set to a correlation value of 0.9 and lowly 
correlated genes set to a correlation value of 0.1. An example of how the mean and correlation 
were simulated will be as follows when considering a gene expression experiment with eight 
genes. The first two genes will correspond to the genes simulated to be LE/LC, followed by the 
next two genes simulated to be LE/HC, then two genes simulated to be HE/LC, and the last two 
genes simulated to be HE/HC. The population means vector will be as follows using the values 
from Table 3.5, with N representing the normal vector and D representing the disease vector: 
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𝜇𝑁 =  
(
 
 
 
 
 
1
1
1
1
5
5
5
5)
 
 
 
 
 
𝑎𝑛𝑑 𝜇𝐷 =  
(
 
 
 
 
 
1.025
1.025
1.025
1.025
10
10
10
10 )
 
 
 
 
 
  
The population correlation matrix were then simulated as follows using the values from Table 
3.5,  
𝜌𝑁 =
(
 
 
 
 
 
1
0.1
0
0
0
0
0
0
  
0.1
1
0
0
0
0
0
0
0
0
   
1
0.1
0
0
0
0
0
0
  
0.1
1
0
0
0
0
0
0
  
0
0
1
0.1
0
0
0
0
  
0
0
0.1
1
0
0
0
0
  
0
0
0
0
1
0.1
   
0
0
0
0
0
0
0.1
1 )
 
 
 
 
 
 
 and  
𝜌𝐷 =
(
 
 
 
 
 
1
0.1
0
0
0
0
0
0
  
0.1
1
0
0
0
0
0
0
0
0
   
1
0.9
0
0
0
0
0
0
  
0.9
1
0
0
0
0
0
0
  
0
0
1
0.1
0
0
0
0
  
0
0
0.1
1
0
0
0
0
  
0
0
0
0
1
0.9
   
0
0
0
0
0
0
0.9
1 )
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Table 3.5. 
Normal Simulations Construction Values for Mean and Correlation 
  
Low 
DC 
High  
DC 
Low DE 
Normal: 
 μ = 1 and 𝜌 = 0.1 
Disease:  
μ = 1.025 and 𝜌 = 0.1 
Normal:  
μ = 1 and 𝜌 = 0.1 
Disease:  
μ = 1.025 and 𝜌 = 0.9 
High DE 
Normal:  
μ = 5 and 𝜌 = 0.1 
Disease:  
μ = 10 and  𝜌 = 0.1 
Normal: 
 μ = 5 and  𝜌 = 0.1 
Disease:  
μ = 10 and 𝜌 = 0.9 
 
Our variance was simulated from the following inverse gamma distribution,  
(
1
σi2
| 𝑑𝑜 , 𝑠𝑜
2) ~Gamma(
do
2
,
doso
2
2
) 
In order to obtain realistic values for, 𝑑𝑜 and 𝑠𝑜
2, we used values that were estimated from a 
previous microarray experiment and then corrected for their degrees of freedom. The following 
correction was performed on 𝑑𝑜 in order to correct for the degrees of freedom,  
do
∗ = do ∗  
n1 + n2 − 2
15
 
Where 15 is the degree of freedom associated with the original 𝑑𝑜‘s microarray experiment. The 
following formula was used to ensure that each that each gene has the same variance across 
conditions but that each gene will have a different variance, Σ = CDC′, where C  is a diagonal 
matrix from our gamma distribution and D is the correlation matrix for the given partitions 
normal and disease state. An example of D is a matrix with a diagonal of one and all other values 
set to the correlation value. For each simulated data set, we perform the DECODE method using 
the regular and moderated test statistics.  
 
 20 
Since our data were simulated such that the mean and variance were specified, we were 
able to find the genes in a given partition based on the thresholds found using the test statistics. 
After the DECODE method finds all 𝑚 partitions, the functional gene sets are found using only 
the genes in the high DE and high DC partition. Due to this, we will focus on the genes identified 
as HE/HC by the DECODE method and compare these to the true HE/HC genes. 
The simulations were performed by simulating data from experiments with sample sizes 
of 4, 6, 8, 10, 12, 16, 20, 40, 60, 80, and 100 for the normal and disease state and with 400, 1000, 
3000, and 5000 genes for each sample size. The total normal simulation step ups were 44 with 50 
replications of each. However, for simulations involving 5000 genes, only 20 replications were 
preformed due to processing time.   
3.3.2. Microarray Simulations 
3.3.2.1. Microarray Simulations (Breast Cancer) 
The Malaysian breast cancer was chosen since it was used in the original DECODE 
paper. The Malaysian breast cancer data set (GSE15852) consists of 86 total samples where 43 
were from the disease breast cancer tissue and 43 samples from the same patient’s normal breast 
tissue (Gene Expression Omnibus (GSE15852), 2009) (NI, 2010). There are a total of 22,283 
genes in this data set. In order to compare found HE/HC genes against the true HE/HC genes, we 
will consider the entire set of genes as the population. 
The simulations were performed by simulating data from experiments with sample sizes 
of 4, 6, 8, 10, 12, 16, and 20 from each of the disease states with 400, 1000, 3000, and 5000 
genes for each sample size.  The total microarray breast cancer simulation step ups were 28 with 
50 replications of each.  
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3.3.2.2. Microarray Simulations (Psoriatic) 
The psoriatic data set (GSE13355) consists of 180 samples from three different disease 
states, for this research the normal (NN) and the disease (PP) samples were chosen. There were a 
total of 64 normal samples and 58 disease samples (Gene Expression Omnibus (GSE13355), 
2009) (Nair, Duffin, Helms, & Ding, 2009). There are over 54,000 genes studied in this data set, 
however due to processor requirements 25,000 genes were chosen at random for this simulation. 
The 25,000 genes will be considered as the entire population in order to find the true high DE 
high DC genes.    
The simulations were performed by taking samples of size 4, 6, 8, 10, 12, 16, and 20 
from each of the disease states and for each sample size we will take a random sample of 400, 
1000, 3000, and 5000 genes from the 25,000 genes. The total microarray psoriatic simulation 
step ups were 28 with 50 replications of each. 
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CHAPTER 4. RESULTS 
In order to compare the performance of the traditional and modified DECODE method; 
we will use simulation studies to compare the sensitivity, PPV, FDR, and overall error rates. The 
better performing method will have a higher average sensitivity and PPV and lower average FDR 
and overall error rate. In the interest of comparing the test statistics, we will evaluate the average 
sensitivity, PPV, FDR, and overall error rate for the normal simulations, breast cancer 
simulations, and the psoriatic simulations separately. 
4.1. Normal Simulation Results  
An analysis of the sensitivity values shows for larger samples of (n=16 and =20) there is 
a large increase in the sensitivity values. However as the number of samples decreases less of a 
difference is seen, with the traditional test statistic performing better at times or almost 
equivalent. Note that the sensitivity values do not tend to increase as the number of genes 
increases, the sensitivity values decrease while the number of genes increase. Figure 4.1 shows 
that in disregard to the sample size, sensitivity values decrease as the number of genes increase. 
The sensitivity also increases along with the sample size; the sensitivity for a sample size of four 
is around 0.06 while the sensitivity for a sample size of 20 is around 0.30.   
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Figure 4.1. Average Sensitivity Values by Sample Size (4-20) by Test Statistic for Normal 
Simulations 
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Comparison analysis of FDR and PPV will return the same result; FDR is complement of 
the PPV. If the moderated test statistic is superior to the traditional, it will have smaller false 
discovery rates, FDR. For the normal simulations, however an analysis of the FDR shows this is 
not the case. In the normal simulations the traditional test statistic had lower average FDRs, with 
the exception of the sample size of four and 3000 genes. A closer look at the simulation with a 
sample size of four shows that the FDRs for the moderated test statistic approaches the 
traditional result. It is noteworthy that as the sample size increases the FDR decreases, showing 
that the DECODE method returned more correct classifications for HE/HC genes with a larger 
sample size. For the sensitivity results, we see an increase in sensitivity as the sample size 
increase, this result as follows in the FDR’s. The FDR’s decrease as the sample size increases, 
thus showing that the DECODE methods reliability increases as the number of samples increase 
with disregard to the test statistic.   
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Figure 4.2. Average FDR Values by Sample Size (4-20) by Test Statistic for Normal Simulations 
For the sensitivity and the FDR, we were able to see a clear difference in the results for 
each sample size; however that is not the case for the overall error rates. Analysis of the overall 
error rates are difficult to interpret. There is a clear decrease in the overall error rate for a sample 
size of four when the moderated test statistic is used, along with a decrease in overall error rate 
as the number of genes increases. This is evidence to show that as the for a sample size of four 
the moderate test statistic is a more suitable test statistic. However, a large uptick in overall error 
rate can be seen for the moderated test statistic all other sample sizes, where the traditional test 
statistic performs better. 
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Figure 4.3. Average Overall Error Rate Values by Sample Size (4-20) by Test Statistic for 
Normal Simulations 
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4.2. Breast Cancer Simulation Results 
The Malaysian Breast Cancer study results were chosen to gain a better insight of how 
the DECODE methods would perform on real microarray data. The results of the normal 
simulations showed a clear pattern of the sensitivity results for the moderated and traditional test 
statistic, however this pattern is not as apparent in the breast cancer sensitivity results. The 
sensitivity values are very similar for the moderated and the traditional test statistics. For the 
large sample sizes, there is a clear uptick in the sensitivity values for the moderated statistic, but 
not for a sample size of four or six. Our two smallest samples sizes returned almost equivalent 
sensitivity values. The sensitivity results for the moderated and the traditional test statistic are so 
close related for the breast cancer simulations that we are unable to say there is any real 
difference between the results of the two test statistics. 
Note that for the normal simulations, the sensitivity results started around 0.06 and 
increased as the sample size increased. For the breast cancer simulations, the sensitivity results 
start around 0.2 and increase as the sample size increases. Thusly, microarray simulations 
returned slightly higher sensitivity values; this can be attributed to the presence of the underlying 
structures in microarray simulations.   
 28 
 
Figure 4.4. Average Sensitivity Values by Sample Size by Test Statistic for Breast Cancer 
Simulations 
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For the FDR, the results of the DECODE method using the moderated test statistic must 
exceed the traditional in order to be considered an improvement. For the two smallest sample 
sizes, the FDRs are similar between the two methods; a slight detectable decrease is noted for the 
moderated test statistic. We wouldn’t expect the moderated test statistic to outperform the 
traditional test statistic in large samples to the same extent in the small sample sizes. However 
for the FDRs for the breast cancer simulation with n= 16 and n = 20 , the moderated returns 
slightly lower FDRs. This difference then extends to sample sizes of 8, 10 and 12 where a 
slightly larger decrease in noted for the moderated test statistic’s FDR. The larger sample sizes 
also return smaller FDR’s than that of the smaller samples. The FDR’s also decreased as the 
sample sizes increased; this same result was seen in our normal simulations.  
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Figure 4.5. Average FDR Values by Sample Size by Test Statistic for Breast Cancer Simulations 
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4.3. Psoriatic Simulation Results  
The Psoriatic simulations were performed with the goal of seeing whether the same 
results were seen as the Breast Cancer simulations. For the normal simulations and the breast 
cancer simulations, the FDR’s were closely related with the moderated surpassing the traditional 
at times. For the Psoriatic simulations the moderated test statistic is seen to perform better than 
the traditional except with a sample size of 20. For the small sample sizes (n=4 and n=6) only a 
slight difference in FDR is noted for the moderated test statistic with the traditional performing 
marginally better for a sample of 3000 genes and 5000 genes. This result is potentially due to the 
poor estimation of DC for the smaller sample sizes. This result shows evidence to support that 
hypothesis that the moderated test statistic is an improvement when used for smaller sample sizes 
with the exception of a sample size of four. All of simulations showed that as the sample size 
increases the FDR’s decrease, showing that when possible a larger sample size should be used in 
order to decrease the FDR’s. 
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Figure 4.6. Average FDR Values by Sample Size by Test Statistic for Psoriatic Simulations 
In the psoriatic simulations the average sensitivity, the proportion of genes that truly are 
HE/HC and found to be HE/HC, varies for each sample size. The trend of decreasing sensitivity 
as the sample size decreases in not as noticeable for these results. The sensitivities for a sample 
size of four are larger than that for sample sizes of six and eight. In the two previous simulations, 
a decreasing sensitivity was seen as the sample size decreased. The results for sensitivity are 
different than expected however still showing that a large sensitivity is gained by using the 
moderated test statistic with the exception of n=16 where the sensitivity appears to be lower.  
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Figure 4.7. Average Sensitivity Values by Sample Size by Test Statistic for Psoriatic 
Simulations 
In the normal simulations, the overall error rate increased as the sample size increased. 
However in the psoriatic simulations the overall error rate fell as the sample size increased. From 
Figure 4.8, it can be seen that the overall error rate was greatly decreased by the moderated test 
statistic for the sample size of four. Then as the sample size increase to 20 there become a less 
noticeable difference in the test statistics with the traditional performing better with a sample size 
of 12, 16, and 20.  
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Figure 4.8. Average Overall Error Rate Values by Sample Size by Test Statistic for Psoriatic 
Simulations 
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CHAPTER 5. CONCLUSION AND DISCUSSION 
5.1. Conclusion 
In this research, the moderated test statistic and the traditional test statistic were 
compared when implementing the DECODE method for gene expression analysis. The 
hypothesis of this research was that using the moderated test statistic for estimating differential 
expression would be superior to using traditional test statistic for experiments with smaller 
sample sizes. In order to investigate this hypothesis, simulation studies were performed.  
It was expected that there would be a sizable different in the sensitivity, PPV, FDR, and 
overall error rate for the moderated test statistic. However a lesser difference than expected was 
seen in the normal, breast cancer, and psoriatic simulations. A slight uptick in sensitivity was 
notice in all three simulations, with the most noticeable results seen in the breast cancer 
simulations. As for the FDR results, the moderated test statistic returned smaller results for both 
microarray simulations studies but not for the normal simulation study. Since the moderated test 
statistic was seen as an improvement to the FDR results for both microarray simulations, we can 
assume that the result was not seen in the normal due to the missing underlying gene structure. In 
regards to the overall error rate, only slight differences were seen in the breast cancer 
simulations, with more noticeable differences seen in the normal and psoriatic simulations. For 
the normal and psoriatic simulations there a noticeable decrease in the overall error rate for a 
sample of size four, with less difference seen as the sample size increased. This is the most 
noticeable in the psoriatic overall error rate simulations (Figure 4.8). 
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5.2. Recommendations  
Even though the results were not as contrasting as expected, the moderated test statistic 
performed marginally better than the traditional test statistic in most cases when sample sizes 
were small. The one exception to this was with the smallest sample size, n=4, when the 
traditional statistic performed better. In my opinion, I would suggest using the moderated 
statistic in the DECODE method for all sample sizes. I make this suggestion even for large 
sample sizes considering the results were similar for the large sample sizes if not equivalent. 
Furthermore, the DECODE method returns smaller FDR and large sensitivity values for larger 
sample sizes. It would be recommendable to use a larger sample size when possible for the 
DECODE method. 
5.3. Future Work  
When considering Sensitivity, PPV, FDR, and overall error rate for all three simulations 
with a sample size of four, the results were similar for the moderated and traditional test 
statistics. This result may be due to the sample size needed for calculation of the Z measure. In 
the methodology for the Z measure, it was noted that the smallest possible sample size was four.  
For future research, it would be advantageous to implement a different method of differential co-
expression in order to apply this method to even smaller gene expression studies. A new method 
of differential co-expression maybe beneficial for sample sizes between 4 and 10, considering 
that de la Fuente A stated that more than 10 replicates is need for a reliable result (de la Fuente, 
2010).  
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APPENDIX. TABLES 
Table A1 
DECODE Method with Traditional Test Statistic (Normal Simulations with 400 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
100 0.5208 0.0574 0.6019 0.0665 0.3981 0.0665 0.1363 0.0159 
80 0.4628 0.0550 0.5097 0.0661 0.4903 0.0661 0.1622 0.0166 
60 0.4398 0.0570 0.5390 0.0655 0.4610 0.0655 0.1580 0.0155 
40 0.4457 0.0514 0.5650 0.0631 0.4350 0.0631 0.1184 0.0220 
20 0.2690 0.0402 0.4535 0.0639 0.5465 0.0639 0.1695 0.0186 
16 0.1983 0.0291 0.3584 0.0620 0.6416 0.0620 0.1777 0.0141 
12 0.2596 0.0347 0.4151 0.0593 0.5849 0.0593 0.1663 0.0205 
10 0.1856 0.0264 0.2798 0.0521 0.7202 0.0521 0.1498 0.0115 
8 0.1977 0.0329 0.2777 0.0537 0.7223 0.0537 0.1303 0.0203 
6 0.1376 0.0260 0.1997 0.0424 0.8003 0.0424 0.1413 0.0150 
4 0.0569 0.0159 0.1067 0.0356 0.8933 0.0356 0.1713 0.0234 
 
Table A2 
DECODE Method with Moderated Test Statistic (Normal Simulations with 400 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
100 0.5512 0.0592 0.5952 0.0659 0.4048 0.0659 0.1305 0.0164 
80 0.5215 0.0560 0.5248 0.0649 0.4752 0.0649 0.1537 0.0173 
60 0.4790 0.0583 0.5281 0.0642 0.4719 0.0642 0.1537 0.0160 
40 0.4984 0.0549 0.5505 0.0616 0.4495 0.0616 0.1508 0.0173 
20 0.3003 0.0451 0.4319 0.0623 0.5681 0.0623 0.1729 0.0194 
16 0.2375 0.0342 0.3526 0.0588 0.6474 0.0588 0.1850 0.0150 
12 0.2770 0.0379 0.3984 0.0589 0.6016 0.0589 0.1711 0.0206 
10 0.1977 0.0296 0.2686 0.0511 0.7314 0.0511 0.1563 0.0124 
8 0.2357 0.0348 0.3479 0.0545 0.6521 0.0545 0.1310 0.0173 
6 0.1542 0.0290 0.2144 0.0447 0.7856 0.0447 0.1353 0.0146 
4 0.0538 0.0159 0.1009 0.0345 0.8991 0.0345 0.1759 0.0226 
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Table A3 
DECODE Method with Traditional Test Statistic (Normal Simulations with 1000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
100 0.3571 0.0565 0.3665 0.0662 0.6335 0.0662 0.1820 0.0151 
80 0.5416 0.0572 0.5888 0.0653 0.4112 0.0653 0.1354 0.0158 
60 0.4727 0.0552 0.5585 0.0651 0.4415 0.0651 0.1501 0.0145 
40 0.3948 0.0502 0.5032 0.0660 0.4968 0.0660 0.1584 0.0136 
20 0.3601 0.0434 0.4786 0.0622 0.5214 0.0622 0.1554 0.0133 
16 0.2422 0.0384 0.3605 0.0605 0.6395 0.0605 0.1516 0.0120 
12 0.2370 0.0340 0.3419 0.0582 0.6581 0.0582 0.1595 0.0142 
10 0.1862 0.0286 0.3005 0.0566 0.6995 0.0566 0.1634 0.0160 
8 0.2092 0.0314 0.2500 0.0504 0.7500 0.0504 0.1162 0.0085 
6 0.1845 0.0287 0.2449 0.0484 0.7551 0.0484 0.1200 0.0110 
4 0.0537 0.0156 0.0580 0.0202 0.9420 0.0202 0.1104 0.0144 
 
Table A4 
DECODE Method with Moderated Test Statistic (Normal Simulations with 1000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
100 0.3746 0.0580 0.3633 0.0656 0.6367 0.0656 0.1794 0.0156 
80 0.5758 0.0592 0.5843 0.0648 0.4157 0.0648 0.1293 0.0164 
60 0.5189 0.0583 0.5547 0.0645 0.4453 0.0645 0.1420 0.0154 
40 0.4485 0.0553 0.4914 0.0644 0.5086 0.0644 0.1564 0.0148 
20 0.3986 0.0474 0.4634 0.0607 0.5366 0.0607 0.1578 0.0138 
16 0.2708 0.0431 0.3457 0.0592 0.6543 0.0592 0.1588 0.0133 
12 0.2469 0.0378 0.3233 0.0561 0.6767 0.0561 0.1658 0.0146 
10 0.1969 0.0321 0.2894 0.0556 0.7106 0.0556 0.1668 0.0161 
8 0.2171 0.0358 0.2400 0.0504 0.7600 0.0504 0.1260 0.0100 
6 0.1780 0.0323 0.2308 0.0482 0.7692 0.0482 0.1133 0.0110 
4 0.0396 0.0124 0.0491 0.0218 0.9509 0.0218 0.1013 0.0144 
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Table A5 
DECODE Method with Traditional Test Statistic (Normal Simulations with 3000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
100 0.4392 0.0589 0.5053 0.0688 0.4947 0.0688 0.1567 0.0159 
80 0.4612 0.0589 0.4875 0.0664 0.5125 0.0664 0.1587 0.0157 
60 0.4474 0.0592 0.4778 0.0655 0.5222 0.0655 0.1618 0.0165 
40 0.4548 0.0526 0.5524 0.0642 0.4476 0.0642 0.1518 0.0151 
20 0.2579 0.0424 0.3399 0.0605 0.6601 0.0605 0.1734 0.0165 
16 0.1993 0.0364 0.2794 0.0584 0.7206 0.0584 0.1622 0.0126 
12 0.1845 0.0319 0.2657 0.0569 0.7343 0.0569 0.1312 0.0070 
10 0.1574 0.0294 0.2174 0.0518 0.7826 0.0518 0.1360 0.0115 
8 0.2259 0.0349 0.3016 0.0566 0.6984 0.0566 0.1004 0.0079 
6 0.1420 0.0277 0.1646 0.0424 0.8354 0.0424 0.0936 0.0113 
4 0.0228 0.0117 0.0287 0.0169 0.9713 0.0169 0.1033 0.0121 
 
Table A6 
DECODE Method with Moderated Test Statistic (Normal Simulations with 3000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
100 0.4729 0.0612 0.5008 0.0682 0.4992 0.0682 0.1503 0.0165 
80 0.4761 0.0605 0.4849 0.0662 0.5151 0.0662 0.1554 0.0160 
60 0.4680 0.0604 0.4866 0.0644 0.5134 0.0644 0.1625 0.0175 
40 0.5006 0.0570 0.5394 0.0629 0.4606 0.0629 0.1480 0.0161 
20 0.2778 0.0466 0.3283 0.0588 0.6717 0.0588 0.1824 0.0169 
16 0.2216 0.0394 0.2726 0.0573 0.7274 0.0573 0.1706 0.0129 
12 0.1955 0.0359 0.2556 0.0556 0.7444 0.0556 0.1468 0.0081 
10 0.1484 0.0304 0.1944 0.0493 0.8056 0.0493 0.1432 0.0117 
8 0.2203 0.0374 0.2695 0.0535 0.7305 0.0535 0.1055 0.0081 
6 0.1292 0.0265 0.1423 0.0401 0.8577 0.0401 0.0994 0.0112 
4 0.0351 0.0168 0.0407 0.0216 0.9593 0.0216 0.0903 0.0118 
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Table A7 
DECODE Method with Traditional Test Statistic (Normal Simulations with 5000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
100 0.4986 0.1010 0.4769 0.1082 0.5231 0.1082 0.1475 0.0275 
80 0.4116 0.0909 0.4741 0.1078 0.5259 0.1078 0.1684 0.0246 
60 0.5838 0.0947 0.5907 0.0991 0.4093 0.0991 0.1274 0.0248 
40 0.6138 0.0846 0.6292 0.0935 0.3708 0.0935 0.1099 0.0201 
20 0.2658 0.0714 0.3658 0.1019 0.6342 0.1019 0.1658 0.0200 
16 0.2847 0.0685 0.4570 0.1043 0.5430 0.1043 0.1336 0.0132 
12 0.2397 0.0575 0.3685 0.1003 0.6315 0.1003 0.1253 0.0091 
10 0.2409 0.0567 0.3587 0.0966 0.6413 0.0966 0.1150 0.0134 
8 0.1842 0.0462 0.2347 0.0846 0.7653 0.0846 0.1322 0.0204 
6 0.1212 0.0401 0.1451 0.0607 0.8549 0.0607 0.1336 0.0254 
4 0.0224 0.0224 0.0328 0.0328 0.9672 0.0328 0.0798 0.0088 
 
Table A8 
DECODE Method with Moderated Test Statistic (Normal Simulations with 5000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
100 0.5046 0.1033 0.4754 0.1082 0.5246 0.1082 0.1451 0.0277 
80 0.4513 0.0926 0.4692 0.1063 0.5308 0.1063 0.1621 0.0254 
60 0.6133 0.0994 0.5812 0.0973 0.4188 0.0973 0.1251 0.0257 
40 0.6459 0.0897 0.6167 0.0923 0.3833 0.0923 0.1082 0.0211 
20 0.2948 0.0795 0.3581 0.0998 0.6419 0.0998 0.1843 0.0238 
16 0.3161 0.0746 0.4440 0.1016 0.5560 0.1016 0.1373 0.0148 
12 0.2591 0.0642 0.3549 0.0972 0.6451 0.0972 0.1359 0.0106 
10 0.2646 0.0638 0.3406 0.0925 0.6594 0.0925 0.1235 0.0144 
8 0.1852 0.0518 0.2228 0.0827 0.7772 0.0827 0.1352 0.0217 
6 0.1273 0.0415 0.1409 0.0604 0.8591 0.0604 0.1446 0.0257 
4 0.0252 0.0252 0.0362 0.0362 0.9638 0.0362 0.0699 0.0099 
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Table A9 
DECODE Method with Traditional Test Statistic (Breast Cancer Simulations with 400 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.4904 0.0260 0.4811 0.0204 0.5189 0.0204 0.0601 0.0089 
16 0.4279 0.0268 0.3499 0.0211 0.6501 0.0211 0.0844 0.0088 
12 0.3931 0.0306 0.2870 0.0237 0.7130 0.0237 0.1298 0.0138 
10 0.3937 0.0272 0.2684 0.0188 0.7316 0.0188 0.1058 0.0124 
8 0.3300 0.0286 0.2315 0.0227 0.7685 0.0227 0.1690 0.0158 
6 0.2997 0.0314 0.1935 0.0250 0.8065 0.0250 0.2103 0.0203 
4 0.3197 0.0303 0.2128 0.0282 0.7872 0.0282 0.2434 0.0179 
 
Table A10 
DECODE Method with Moderated Test Statistic (Breast Cancer Simulations with 400 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.4854 0.0269 0.4667 0.0188 0.5333 0.0188 0.0599 0.0089 
16 0.4355 0.0276 0.3498 0.0205 0.6502 0.0205 0.0867 0.0092 
12 0.3947 0.0317 0.2835 0.0241 0.7165 0.0241 0.1276 0.0140 
10 0.3837 0.0250 0.2620 0.0186 0.7380 0.0186 0.1089 0.0126 
8 0.3181 0.0302 0.2180 0.0242 0.7820 0.0242 0.1681 0.0162 
6 0.3221 0.0335 0.2107 0.0277 0.7893 0.0277 0.1989 0.0189 
4 0.3265 0.0314 0.2156 0.0289 0.7844 0.0289 0.2397 0.0186 
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Table A11 
DECODE Method with Traditional Test Statistic (Breast Cancer Simulations with 1000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.5768 0.0318 0.4698 0.0213 0.5302 0.0213 0.0306 0.0045 
16 0.5026 0.0294 0.4016 0.0227 0.5984 0.0227 0.0483 0.0094 
12 0.4234 0.0305 0.2766 0.0195 0.7234 0.0195 0.0761 0.0117 
10 0.3234 0.0339 0.2077 0.0169 0.7923 0.0169 0.0981 0.0118 
8 0.3337 0.0284 0.1848 0.0128 0.8152 0.0128 0.1056 0.0135 
6 0.1955 0.0228 0.1315 0.0162 0.8685 0.0162 0.1452 0.0157 
4 0.2407 0.0241 0.1226 0.0142 0.8774 0.0142 0.1883 0.0185 
 
Table A12 
DECODE Method with Moderated Test Statistic (Breast Cancer Simulations with 1000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.5827 0.0323 0.4740 0.0217 0.5260 0.0217 0.0300 0.0044 
16 0.4972 0.0286 0.4043 0.0251 0.5957 0.0251 0.0474 0.0089 
12 0.4295 0.0312 0.2821 0.0202 0.7179 0.0202 0.0811 0.0130 
10 0.3236 0.0342 0.2073 0.0180 0.7927 0.0180 0.0973 0.0126 
8 0.3385 0.0286 0.1912 0.0135 0.8088 0.0135 0.1039 0.0140 
6 0.2099 0.0220 0.1314 0.0136 0.8686 0.0136 0.1401 0.0142 
4 0.2582 0.0246 0.1283 0.0132 0.8717 0.0132 0.1938 0.0189 
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Table A13 
DECODE Method with Traditional Test Statistic (Breast Cancer Simulations with 3000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.6964 0.0275 0.4750 0.0156 0.5250 0.0156 0.0136 0.0007 
16 0.5817 0.0387 0.3740 0.0214 0.6260 0.0214 0.0250 0.0059 
12 0.3781 0.0358 0.2106 0.0153 0.7894 0.0153 0.0682 0.0126 
10 0.4670 0.0319 0.2617 0.0140 0.7383 0.0140 0.0455 0.0093 
8 0.2924 0.0344 0.1490 0.0130 0.8510 0.0130 0.0741 0.0099 
6 0.2079 0.0198 0.1313 0.0109 0.8687 0.0109 0.1336 0.0141 
4 0.2181 0.0218 0.1295 0.0111 0.8705 0.0111 0.2027 0.0143 
 
Table A14 
DECODE Method with Moderated Test Statistic (Breast Cancer Simulations with 3000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.7020 0.0264 0.4809 0.0155 0.5191 0.0155 0.0133 0.0006 
16 0.5858 0.0390 0.3851 0.0220 0.6149 0.0220 0.0261 0.0065 
12 0.3921 0.0365 0.2220 0.0160 0.7780 0.0160 0.0729 0.0136 
10 0.4839 0.0339 0.2748 0.0140 0.7252 0.0140 0.0454 0.0099 
8 0.3105 0.0335 0.1604 0.0125 0.8396 0.0125 0.0765 0.0105 
6 0.2088 0.0200 0.1304 0.0097 0.8696 0.0097 0.1323 0.0140 
4 0.2270 0.0230 0.1317 0.0112 0.8683 0.0112 0.2095 0.0155 
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Table A15 
DECODE Method with Traditional Test Statistic (Breast Cancer Simulations with 5000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.7302 0.0284 0.4426 0.0186 0.5574 0.0186 0.0108 0.0005 
16 0.6815 0.0335 0.3584 0.0164 0.6416 0.0164 0.0195 0.0034 
12 0.4970 0.0377 0.2660 0.0156 0.7340 0.0156 0.0457 0.0095 
10 0.4671 0.0436 0.2126 0.0125 0.7874 0.0125 0.0508 0.0088 
8 0.2938 0.0375 0.1578 0.0127 0.8422 0.0127 0.0791 0.0127 
6 0.2533 0.0270 0.1410 0.0102 0.8590 0.0102 0.1447 0.0138 
4 0.2058 0.0168 0.1471 0.0097 0.8529 0.0097 0.2094 0.0126 
 
Table A16 
DECODE Method with Moderated Test Statistic (Breast Cancer Simulations with 5000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.7348 0.0284 0.4468 0.0187 0.5532 0.0187 0.0109 0.0005 
16 0.6812 0.0329 0.3617 0.0165 0.6383 0.0165 0.0197 0.0033 
12 0.5009 0.0382 0.2785 0.0163 0.7215 0.0163 0.0433 0.0090 
10 0.4730 0.0432 0.2188 0.0126 0.7812 0.0126 0.0540 0.0099 
8 0.3022 0.0368 0.1671 0.0127 0.8329 0.0127 0.0857 0.0129 
6 0.2712 0.0272 0.1481 0.0118 0.8519 0.0118 0.1446 0.0140 
4 0.2123 0.0187 0.1449 0.0105 0.8551 0.0105 0.2061 0.0134 
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Table A17 
DECODE Method with Traditional Test Statistic (Psoriatic Simulations with 400 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.4841 0.0285 0.4326 0.0196 0.5674 0.0196 0.0874 0.0089 
16 0.4218 0.0316 0.3483 0.0228 0.6517 0.0228 0.0945 0.0099 
12 0.3422 0.0295 0.2871 0.0210 0.7129 0.0210 0.1169 0.0120 
10 0.2903 0.0305 0.2713 0.0244 0.7287 0.0244 0.1406 0.0141 
8 0.2803 0.0332 0.2080 0.0214 0.7920 0.0214 0.1451 0.0146 
6 0.2832 0.0367 0.1798 0.0216 0.8202 0.0216 0.1825 0.0177 
4 0.4189 0.0397 0.2699 0.0364 0.7301 0.0364 0.2561 0.0193 
 
Table A18 
DECODE Method with Moderated Test Statistic (Psoriatic Simulations with 400 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.4989 0.0291 0.4427 0.0193 0.5573 0.0193 0.0848 0.0087 
16 0.4207 0.0315 0.3409 0.0183 0.6591 0.0183 0.0924 0.0097 
12 0.3384 0.0306 0.2722 0.0200 0.7278 0.0200 0.1096 0.0115 
10 0.3065 0.0309 0.2765 0.0241 0.7235 0.0241 0.1381 0.0133 
8 0.3048 0.0361 0.2140 0.0219 0.7860 0.0219 0.1445 0.0143 
6 0.3036 0.0364 0.2077 0.0238 0.7923 0.0238 0.1833 0.0183 
4 0.4186 0.0405 0.2495 0.0339 0.7505 0.0339 0.2446 0.0189 
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Table A19 
DECODE Method with Traditional Test Statistic (Psoriatic Simulations with 1000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.4537 0.0286 0.3747 0.0152 0.6253 0.0152 0.0571 0.0037 
16 0.3806 0.0262 0.3427 0.0155 0.6573 0.0155 0.0742 0.0076 
12 0.3632 0.0305 0.2314 0.0168 0.7686 0.0168 0.0860 0.0092 
10 0.3436 0.0327 0.2135 0.0182 0.7865 0.0182 0.0947 0.0117 
8 0.2189 0.0257 0.1603 0.0180 0.8397 0.0180 0.0910 0.0084 
6 0.2613 0.0304 0.1818 0.0172 0.8182 0.0172 0.1506 0.0155 
4 0.3402 0.0336 0.1333 0.0147 0.8667 0.0147 0.2204 0.0183 
 
Table A20 
DECODE Method with Moderated Test Statistic (Psoriatic Simulations with 1000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.4589 0.0297 0.3826 0.0135 0.6174 0.0135 0.0571 0.0037 
16 0.3783 0.0266 0.3405 0.0162 0.6595 0.0162 0.0706 0.0062 
12 0.3642 0.0300 0.2406 0.0160 0.7594 0.0160 0.0832 0.0084 
10 0.3456 0.0330 0.2087 0.0191 0.7913 0.0191 0.0909 0.0106 
8 0.2168 0.0249 0.1625 0.0186 0.8375 0.0186 0.0873 0.0083 
6 0.2747 0.0305 0.1806 0.0171 0.8194 0.0171 0.1423 0.0151 
4 0.3768 0.0343 0.1414 0.0135 0.8586 0.0135 0.2251 0.0182 
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Table A21 
DECODE Method with Traditional Test Statistic (Psoriatic Simulations with 3000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.4955 0.0295 0.3761 0.0147 0.6239 0.0147 0.0519 0.0047 
16 0.4402 0.0308 0.3432 0.0171 0.6568 0.0171 0.0590 0.0052 
12 0.4232 0.0332 0.2533 0.0154 0.7467 0.0154 0.0785 0.0074 
10 0.2697 0.0286 0.2043 0.0168 0.7957 0.0168 0.0749 0.0086 
8 0.3103 0.0305 0.1773 0.0152 0.8227 0.0152 0.1069 0.0091 
6 0.2765 0.0237 0.1563 0.0136 0.8437 0.0136 0.1412 0.0117 
4 0.3032 0.0245 0.1382 0.0134 0.8618 0.0134 0.2302 0.0168 
 
Table A22 
DECODE Method with Moderated Test Statistic (Psoriatic Simulations with 3000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.4968 0.0297 0.3769 0.0130 0.6231 0.0130 0.0510 0.0038 
16 0.4328 0.0316 0.3572 0.0174 0.6428 0.0174 0.0569 0.0052 
12 0.4256 0.0326 0.2632 0.0154 0.7368 0.0154 0.0781 0.0067 
10 0.2858 0.0290 0.2193 0.0181 0.7807 0.0181 0.0816 0.0092 
8 0.3226 0.0299 0.1887 0.0161 0.8113 0.0161 0.1138 0.0098 
6 0.2888 0.0253 0.1600 0.0145 0.8400 0.0145 0.1415 0.0120 
4 0.3026 0.0250 0.1318 0.0125 0.8682 0.0125 0.2136 0.0161 
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Table A23 
DECODE Method with Traditional Test Statistic (Psoriatic Simulations with 5000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.5618 0.0293 0.4372 0.0162 0.5628 0.0162 0.0564 0.0041 
16 0.5059 0.0282 0.3411 0.0141 0.6589 0.0141 0.0738 0.0055 
12 0.3520 0.0282 0.2491 0.0142 0.7509 0.0142 0.0732 0.0061 
10 0.3217 0.0281 0.2096 0.0142 0.7904 0.0142 0.0870 0.0085 
8 0.2852 0.0294 0.1783 0.0145 0.8217 0.0145 0.1088 0.0089 
6 0.2884 0.0242 0.1696 0.0145 0.8304 0.0145 0.1438 0.0140 
4 0.3152 0.0230 0.1553 0.0110 0.8447 0.0110 0.2565 0.0150 
 
Table A24 
DECODE Method with Moderated Test Statistic (Psoriatic Simulations with 5000 genes) 
  Sensitivity PPV FDR Error Rate 
Sample Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error Average 
Standard 
 Error 
20 0.5644 0.0289 0.4397 0.0159 0.5603 0.0159 0.0562 0.0039 
16 0.5071 0.0280 0.3442 0.0143 0.6558 0.0143 0.0713 0.0052 
12 0.3659 0.0288 0.2560 0.0145 0.7440 0.0145 0.0792 0.0066 
10 0.3273 0.0283 0.2080 0.0144 0.7920 0.0144 0.0861 0.0089 
8 0.2976 0.0288 0.1885 0.0139 0.8115 0.0139 0.1144 0.0093 
6 0.2937 0.0257 0.1743 0.0148 0.8257 0.0148 0.1429 0.0139 
4 0.3250 0.0237 0.1477 0.0102 0.8523 0.0102 0.2407 0.0148 
 
 
